Literature DB >> 24317326

Proteomic biomarkers for brain disorders: technical considerations and challenges.

Linda S Brady1, William Z Potter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24317326      PMCID： PMC3857649          DOI： 10.1038/npp.2013.202

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  4 in total

Review 1.  Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.

Authors:  Ju-Hee Kang; Hugo Vanderstichele; John Q Trojanowski; Leslie M Shaw
Journal:  Methods       Date:  2012-04-06       Impact factor: 3.608

2.  Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease.

Authors:  Holly D Soares; William Z Potter; Eve Pickering; Max Kuhn; Frederick W Immermann; David M Shera; Mats Ferm; Robert A Dean; Adam J Simon; Frank Swenson; Judith A Siuciak; June Kaplow; Madhav Thambisetty; Panayiotis Zagouras; Walter J Koroshetz; Hong I Wan; John Q Trojanowski; Leslie M Shaw
Journal:  Arch Neurol       Date:  2012-10

Review 3.  Recent advances in quantitative neuroproteomics.

Authors:  George E Craft; Anshu Chen; Angus C Nairn
Journal:  Methods       Date:  2013-04-25       Impact factor: 3.608

4.  CSF biomarker variability in the Alzheimer's Association quality control program.

Authors:  Niklas Mattsson; Ulf Andreasson; Staffan Persson; Maria C Carrillo; Steven Collins; Sonia Chalbot; Neal Cutler; Diane Dufour-Rainfray; Anne M Fagan; Niels H H Heegaard; Ging-Yuek Robin Hsiung; Bradley Hyman; Khalid Iqbal; Stephan A Kaeser; Stephan A Käser; D Richard Lachno; Alberto Lleó; Piotr Lewczuk; José L Molinuevo; Piero Parchi; Axel Regeniter; Robert A Rissman; Robert Rissman; Hanna Rosenmann; Giuseppe Sancesario; Johannes Schröder; Leslie M Shaw; Charlotte E Teunissen; John Q Trojanowski; Hugo Vanderstichele; Manu Vandijck; Marcel M Verbeek; Henrik Zetterberg; Kaj Blennow
Journal:  Alzheimers Dement       Date:  2013-05       Impact factor: 21.566
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.